No. Recurrence should trigger a disciplined challenge of the previous investigation, but several explanations are possible: the original root cause was wrong, the identified cause was only one contributor, the CAPA did not adequately address the cause, implementation was weak, or the new event arose through a different mechanism that produces a similar outcome.

The previous investigation should be reopened intellectually before it is reopened administratively. Compare the evidence, failure mechanism, equipment, materials, personnel, process conditions, timing, and assumptions behind the earlier conclusion. Pay particular attention to what the original investigation ruled out and why.

Inspection difficulty arises when the second investigation simply references the first conclusion and treats recurrence as another instance of an already understood problem. Recurrence is new evidence. It should test the strength of the earlier RCA.

A previous root cause deserves continued acceptance only if it still explains the evidence better than credible alternatives after the repeat event is considered.

Priority should follow current quality risk and significance rather than record age alone. Aging remains important because prolonged investigations can delay decisions and corrective actions, but closing the oldest records first can direct limited resources toward lower consequence issues while more important signals wait.

A useful backlog review asks what could change the disposition of product, patient risk, process control, regulatory reporting, or the understanding of a recurring problem. Recurrence, emerging trends, unresolved OOS results, potential cross-batch impact, weak containment, and links to previous events should influence priority.

The dangerous metric is a declining backlog count that looks healthy while high-risk records continue aging. Management should be able to explain why one investigation moved ahead of another and what interim controls protect against unresolved risk.

Backlog governance becomes defensible when prioritization decisions remain traceable to risk and new evidence, rather than being driven primarily by closure targets or an aging dashboard.

Their collective significance should be evaluated before continuing to close them as independent minor events. Several individually low-risk records can provide stronger evidence of a systemic weakness when they share equipment, materials, process steps, failure mechanisms, suppliers, personnel practices, or other meaningful characteristics.

The difficulty is that classification systems often fragment the evidence. One event sits in deviations, another in laboratory OOS records, and another in complaints. Each record can appear reasonable when reviewed alone.

Once a plausible connection emerges, the assessment should examine whether the combined evidence changes the original risk judgment or exposes a control that is degrading. That does not automatically require a large CAPA. It does require a documented decision about whether broader investigation or corrective action is warranted.

An inspector reviewing records across systems may identify the pattern before the site does. Repeated low-level signals become harder to defend when organizational boundaries prevented anyone from evaluating them together.

Absence of recurrence is weak evidence when the process has had limited opportunity to fail again. An effectiveness check should consider whether enough relevant exposure has occurred to meaningfully test the corrective action, especially for intermittent, seasonal, campaign-based, or low-frequency problems.

For example, three months without recurrence means little if the affected operation occurred only twice during that period. Calendar time alone can create a false appearance of effectiveness.

The effectiveness criteria should therefore reflect the failure mechanism and the opportunities for recurrence. Relevant evidence might include the number of batches, campaigns, analyses, interventions, equipment cycles, complaints, or other exposures since implementation. Leading indicators can also matter when waiting for the original failure would be an insensitive measure.

Premature effectiveness closure creates rework when the same problem returns and the earlier CAPA must be reassessed. A defensible conclusion explains why the observation period and available evidence were capable of detecting an ineffective action.